The ERAP Clinical Study Group
The ERAP Clinical Study Group
About
People
erap
Publications
Miia Kivipelto
Latest
Pharmacokinetic Analysis of Intermittent Rapamycin Administration in Early-Stage Alzheimer's Disease
Evaluation of rapamycin as a neuroprotective treatment in Alzheimertextquoterights disease: a six-month single-arm open-label clinical pilot trial
Evaluating the effect of rapamycin treatment in Alzheimer’s disease and aging using in vivo imaging: the ERAP phase IIa clinical study protocol
Cite
×